Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings

• Lisa A. de Jong, 
• Jessie Groeneveld, 
• Jelena Stevanovic, 
• Harrie Rila, 
• Robert G. Tieleman, 
• Menno V. Huisman, 
• Maarten J. Postma, 
• Marinus van Hulst